Mitochondrial Metabolism

Mitochondrial Metabolism

Mitochondria use multiple carbon fuels to produce ATP and metabolites, including pyruvate, which is generated from glycolysis; amino acids such as glutamine; and fatty acids. The reducing equivalents NADH and FADH2, which transfer their electrons to the electron transport chain, are produced by these carbon fuels by feeding into the TCA cycle in the mitochondrial matrix. Complex organelles called mitochondria are crucial for many aspects of cellular function, including metabolism, immune control, and cell death.Calcium buffering, lipid flux, and intracellular signaling are just a few of the many cellular processes and molecular interactions that mitochondria actively participate in. It is becoming more widely acknowledged that mitochondrial dysfunction is a defining feature of many diseases, including cancer, cardiovascular, and neurodegenerative conditions. Mitochondrial metabolism influences processes like the epithelial-to-mesenchymal transition, which is a key factor in the progression of tumors. The epigenetic landscape is altered by mitochondrial metabolism and the oncometabolites that result to change the aggressiveness characteristics of cancer cells. Regarding the survival of tumors in response to treatment, changes in mitochondrial metabolism are important.

Mitochondrial Metabolism related products

Structure Cat No. Product Name CAS No. Product Description
V4719 BI-6C9 791835-21-7 BI-6C9 is a novel and potent inhibitor of BH3 interacting domain (Bid) with Kd of 20 µM, it acts by preventing mitochondrial outer membrane potential (MOMP) and mitochondrial fission, and protecting the cells from cell death.
V73521 CP-346086 186390-48-7 CP-346086 is a potent and orally bioactive microsomal triglyceride transfer protein (MTP) inhibitor (antagonist) with IC50 of 2.0 nM for human and rodent MTP.
V73522 CP-346086 dihydrate 1262769-98-1 CP-346086 dihydrate is a potent and orally bioactive microsomal triglyceride transfer protein (MTP) inhibitor (antagonist) with IC50 of 2.0 nM for human and rodent MTP.
V72006 DS44960156 2361327-08-2 DS44960156 is a selective inhibitor of methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) with IC50s of 1.6 μM and >30 μM for MTHFD2 and MTHFD1, respectively.
V73208 DX3-234 2941323-59-5 DX3-234 is an oxidative phosphorylation (OXPHOS) inhibitor.
V73213 DX3-235 2749555-39-1 DX3-235 is an oxidative phosphorylation (OXPHOS) inhibitor.
V29295 ER-000444793 792957-74-5 ER-000444793 is a potent inhibitor of mitochondrial permeability transition pore (mPTP) opening.
V3679 FCCP 370-86-5 FCCP (full name: Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) is an ionophore and often referred to as a mitochondrial uncoupling agent.
V73207 Fenpyroximate 111812-58-9 Fenpyroximate is an acaricide and insecticide used on crops and ornamental plants.
V73200 Fumarate hydratase-IN-2 sodium salt 2070009-45-7 Fumarate hydratase-IN-2 sodium salt (compound 3) is a cell-penetrating/penetrable, competitive inhibitor of fumarate hydratase (Ki=4.5 μM) with nutrient-dependent cell toxicity/cytotoxicity.
V73218 Glutamate dehydrogenase (NAD(P)) (GLDH) 9029-12-3 Glutamate dehydrogenase NAD(P) (GLDH) is found in liver cells, kidney tissue, brain, muscle and intestinal cells.
V2382 GW604714X 853953-65-8 GW604714X is a potent inhibitor of mitochondrial respiration.
V2181 HQNO 341-88-8 HQNO, secreted byP.
V3751 IACS-010759 HCl 1807523-99-4 IACS-10759 HCl (IACS10759; IACS-010759) was identified as a potent and orally bioavailable inhibitor of complex I of oxidative phosphorylation (OXPHOS) with anticancer activity.
V3750 IACS-10759 1570496-34-2 IACS-10759 (IACS10759) is a potent and orally bioavailable inhibitor of OXPHOS (complex I of oxidative phosphorylation) with antitumor effects.
V2310 Idebenone (CV-2619) 58186-27-9 Idebenone (also known as CV-2619)is a synthetic analog of coenzyme Q10 (CoQ10) and a brain stimulant.
V73204 IM176OUT05 1643659-96-4 IM176OUT05 is a highly soluble biguanide.
V5065 KL-1333 1800405-30-4 KL1333,a novel NAD+modulator, is a potent, orally bioavailable and small organic molecule with the potential to treatMitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).
V2257 LDC195943 (IMT1) 2304621-31-4 LDC195943 (also known as IMT1) is a novel, potent and highly specific inhibitor of POLRMT (human mitochondrial RNA polymerase) with anticancer activity.
V73214 Leramistat (HMC-C-01-A; MBS2320) 1642602-54-7 Leramistat (HMC-C-01-A; MBS2320) is a mitochondrial complex 1 inhibitor involved in the regulation of cellular metabolism and immunometabolism.
Contact Us Back to top